1. Home
  2. CELU vs PZG Comparison

CELU vs PZG Comparison

Compare CELU & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • PZG
  • Stock Information
  • Founded
  • CELU 2016
  • PZG 1992
  • Country
  • CELU United States
  • PZG United States
  • Employees
  • CELU N/A
  • PZG N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • PZG Metal Mining
  • Sector
  • CELU Health Care
  • PZG Basic Materials
  • Exchange
  • CELU Nasdaq
  • PZG Nasdaq
  • Market Cap
  • CELU 42.2M
  • PZG 48.4M
  • IPO Year
  • CELU N/A
  • PZG 1999
  • Fundamental
  • Price
  • CELU $3.95
  • PZG $0.78
  • Analyst Decision
  • CELU
  • PZG
  • Analyst Count
  • CELU 0
  • PZG 0
  • Target Price
  • CELU N/A
  • PZG N/A
  • AVG Volume (30 Days)
  • CELU 143.3K
  • PZG 295.4K
  • Earning Date
  • CELU 05-08-2025
  • PZG 09-25-2025
  • Dividend Yield
  • CELU N/A
  • PZG N/A
  • EPS Growth
  • CELU N/A
  • PZG N/A
  • EPS
  • CELU N/A
  • PZG N/A
  • Revenue
  • CELU $54,220,000.00
  • PZG N/A
  • Revenue This Year
  • CELU $23.29
  • PZG N/A
  • Revenue Next Year
  • CELU N/A
  • PZG N/A
  • P/E Ratio
  • CELU N/A
  • PZG N/A
  • Revenue Growth
  • CELU 138.11
  • PZG N/A
  • 52 Week Low
  • CELU $1.00
  • PZG $0.31
  • 52 Week High
  • CELU $5.22
  • PZG $0.78
  • Technical
  • Relative Strength Index (RSI)
  • CELU 59.89
  • PZG 59.34
  • Support Level
  • CELU $3.03
  • PZG $0.66
  • Resistance Level
  • CELU $3.65
  • PZG $0.72
  • Average True Range (ATR)
  • CELU 0.22
  • PZG 0.03
  • MACD
  • CELU -0.02
  • PZG 0.00
  • Stochastic Oscillator
  • CELU 66.37
  • PZG 92.77

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

Share on Social Networks: